抄録
The clinical effect of Celeport® was evaluated in 55 patients (mean age: 67 years), complaining of chronic dizziness or imbalance. Subjective symptoms, objective findings, subjective disability in activities of daily living and quality of life were recorded. The doctors in charge reported some improvement in 76.4% of the patients and noted that Celeport® reduced dizziness in 79.6%. Subjective disability in activities of daily living was significantly improved (p<0.01). Quality of life, especially a feeling of satisfaction with family life was also significantly improved by Celeport® administration (p<0.05). In conclusion, Celeport® was an effective treatment for patients complaining of chronic dizziness or imbalance.
